5 recruiting. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Recruiting 5 |
Follow Suppuration: new trials by email Literature Review of Suppuration trials Research Report on Suppuration
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS Remibrutinib - Hidradenitis Suppurativa | Phase 3 | Recruiting | Novartis Pharmaceuticals | 710 | 2026-07-10 | 2026-10-13 |
| Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Hidradenitis Suppurativa Patients ROCEPHIN, metronidazole, RIFADIN, IZILOX, placebo combination therapy, Lymecyclin and corresponding placebos of the experimental arm - Hidradenitis Suppurativa | Phase 3 | Recruiting | Institut Pasteur | 92 | 2025-05-22 | 2025-07-09 |
| Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib povorcitinib - Hidradenitis Suppurativa (HS) | Phase 3 | Recruiting | Incyte Corporation | 600 | 2025-02-28 | 2026-10-09 |
| Empirical Intravenous Beta-Lactam Plus Metronidazole Vs Oral Cefixime Plus Metronidazole for the Treatment of Liver Abscess Intravenous beta-lactam antimicrobial for 2 weeks Plus Intravenous Metronidazole (750 mg q 8 hourly) for 2 weeks, Tablet Cefixime (200 mg q 12 hourly) for 2 weeks Plus Tablet Metronidazole (800 mg q 8 hourly) for 2 weeks, Standard medical care - Liver Abscess | Phase 3 | Recruiting | Post Graduate Institute of Medical Education and Research, Chandigarh | 220 | 2025-02-25 | 2025-04-13 |
| Laparoscopic Antibiotic Lavage to Prevent Intra-abdominal Abscess Formation in Complicated Appendicitis Laparoscopic antibiotic peritoneal lavage with gentamicin / clindamycin - Complicated Appendicitis, Intra-Abdominal Abscess | Phase 3 | Recruiting | Spaarne Gasthuis | 752 | 2025-02-24 | 2026-10-09 |
Hidradenitis Suppurativa (3) · Abdominal Abscess (1) · Hidradenitis (1) · Liver Abscess (1)
Infections (5) · Bacterial Infections (3) · Bacterial Infections and Mycoses (3) · Skin Diseases (3) · Skin Diseases, Bacterial (3) · Skin Diseases, Infectious (3) · Skin and Connective Tissue Diseases (3) · Sweat Gland Diseases (3) · Abscess (2) · Hidradenitis (2) · Abdominal Abscess (1) · Digestive System Diseases (1) · Liver Diseases (1)
Ceftriaxone (1) · Clindamycin (1) · Gentamicins (1) · Metronidazole (1) · Moxifloxacin (1) · Rifampin (1) · Standard of Care (1) · WW Domain-Containing Oxidoreductase (1) · remibrutinib (1)
Incyte Corporation (1) · Institut Pasteur (1) · Novartis Pharmaceuticals (1) · Post Graduate Institute of Medical Education and Research, Chandigarh (1) · Spaarne Gasthuis (1)
France (3) · Argentina (2) · Australia (2) · Canada (2) · Germany (2) · Netherlands (2) · Spain (2) · United States (2) · Austria (1) · Belgium (1) · Bulgaria (1) · Chile (1) · China (1) · Czechia (1) · Greece (1)
2025 (1)